gdc

Colorectal Cancer

First-Line Treatment with Keytruda Doubles the Time without Disease Progression in Patients with MSI-H or dMMR Metastatic Colorectal Cancer
Colorectal Cancer
ASCO 2020 Highlights – September 8, 2020
New study results presented at the 2020 ASCO annual meeting suggest that there is a new standard of care for the first-line treatment of some patients with advanced colorectal cancer. This was the first study to compare the use of Keytruda (pembrolizumab), a PD-1 inhibitor, versus chemotherapy to see which is the best first treatment for patients with metastatic (spreading) colorectal cancer and microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) abnormalities.
Opdivo plus Yervoy May Be New First-Line Option for Patients with MSI-H or dMMR Colorectal Cancer
Colorectal Cancer
ASCO 2020 Highlights – September 8, 2020
The use of first-line immunotherapy combination with Opdivo (nivolumab) and low-dose Yervoy (ipilimumab) continues to show robust, long-term benefit in patients with microsatellite instability high (MSI-H) or with mismatch repair-deficient (dMMR) metastatic (spreading) colorectal cancer, according to new study results presented at the 2020 ASCO annual meeting.
First-Line Immunotherapy New Standard of Care in Some Patients with Metastatic Colorectal Cancer
Colorectal CancerImmunotherapy
August 2020 – Immunotherapy – August 26, 2020
A new study was presented at the 2020 ASCO meeting that compared, for the first time, the use of immunotherapy versus chemotherapy for treating patients with metastatic colorectal cancer and microsatellite instability-high or mismatch repair-deficient abnormalities.
Learning I Had Lynch Syndrome Helped Save My Life
Colorectal CancerGenetics & CancerPatient Stories
June 2020 Vol 6 No 3 – June 24, 2020
Lynch syndrome is a hereditary genetic abnormality that can cause several types of cancer. Wenora Johnson discovered that it ran in her family after she had treatment for colon cancer. Knowing that she was at a high risk for certain cancers, and having 2 children already, she had her ovaries and uterus removed, as prevention.
Healthy Food Habits for Colon Cancer Risk Reduction and Survivorship
Colorectal CancerNutrition & Cancer
February 2020 Vol 6 No 1 – February 21, 2020
Oncology dietitian Julie Lanford offers tips on how to reduce the risk of colon cancer, as well as strategies for survivors during and after cancer treatment.
Drugs for Colorectal Cancer
Colorectal Cancer
Here are the drugs and financial support services available to patients receiving treatment for Colorectal Cancer.
Recovering from Survivor Guilt After Surviving Hurricane Katrina and Colorectal Cancer
Colorectal CancerPatient Stories
August 2019 Vol 5 No 4 – August 27, 2019
As a psychologist dedicated to helping people cope with disasters, Jamie D. Aten knew the damage “survivor’s guilt” can do. As a stage IV colon cancer survivor, he says, “I wasn’t prepared for it to hit me personally.”
Gift of the Dragonflies
Colorectal CancerPatient Stories
When treatment for advanced colon cancer forced Cindy Simpson Wise to slow her busy pace, she found comfort in surrounding herself with nature’s beauty and in focusing on hope and joy.
My Biomarker Story, and Why I Advocate for Genetic Testing
BiomarkersPatient AdvocacyPatient StoriesColorectal Cancer
Wenora Y. Johnson, 3-time survivor, shares her cancer story and encourages patients to ask their care team about biomarker testing.
Can I Buy a Bowel? 6 Clues That Tell You to Get Screened for Colorectal Cancer
Colorectal Cancer
Web Exclusives – February 28, 2019
Don’t take chances with your health. Many colorectal cancer symptoms are overlooked, so pay attention to these clues.
Page 1 of 3
Results 1 - 10 of 22

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country